US Patent 8431116 Norovirus vaccine formulations
Patent 8431116 was granted and assigned to Takeda (company) on April, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+356 characters)
Article
Patent abstract
The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Charles Richardson0
Thomas R. Foubert0
Thomas S. Vedvick0
William T. Tino0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08431116 Norovirus vaccine formulations US Patent 8431116 Norovirus vaccine formulations
Infobox
Patent Number
08431116
Patent Number
8431116
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08431116 Norovirus vaccine formulations
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08431116
Date of patent
April 30, 2013
Patent application number
12816495
Date Filed
June 16, 2010
Patent primary examiner
Find more entities like US Patent 8431116 Norovirus vaccine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
